Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Sheba Medical Center Carried Out Israel’s First Implant of an Innovative Medtronic Pacemaker

Israel's First Implant
The advanced Medtronic pacemaker does not require a surgical incision to implant, and is now suitable for most patients.

The innovative Medtronic pacemaker Micra was implanted for the first time in Israel at Sheba Medical Center. The procedure entailed inserting a straw-like catheter system to a vein near the upper thigh, dispensing with the surgical incision typically required when implanting a pacemaker.

“The procedure is a simple venous catheterization that’s much easier on the patient compared to the commonly practiced chest incision,” explains Prof. Eyal Nof, Director of the Invasive Electrophysiology Service at Sheba Medical Center. According to Nof, the innovative pacemaker has other advantages, including a decreased risk of infection and related morbidity.

Whereas until recently the use of the new Medtronic pacemaker was only suitable for around 15% of patients with pacing needs, a recent development allows Micra to synchronize the electrical activity of the atrium and ventricle, rendering it applicable to 60-70% of candidates for pacemaker implantation.

According to Roy Beinart, Director of Sheba’s Davidai Arrhythmia Center: “The advanced pacemaker is an important milestone that will allow us to provide hope and solace to countless patients, and improve their quality of life.” In keeping with Sheba’s commitment to medical innovation, Beinart added: “We will continue to lead the way in the development and implementation of advanced and groundbreaking treatments in order to impact the medicine of the future.”

Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More